Evaluation of Dabigatran Bleeding Adverse Reaction Reports in the FDA Adverse Event Reporting System during the First Year of Approval-Reference-Cited by-同舟云学术

Evaluation of Dabigatran Bleeding Adverse Reaction Reports in the FDA Adverse Event Reporting System during the First Year of Approval

Published:2014-03-19 Issue:6 Volume:34 Page:561-569
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

McConeghy Kevin W.¹,Bress Adam¹,Qato Dima M.¹²³,Wing Coady⁴,Nutescu Edith A.¹²³

Affiliation:

1. Department of Pharmacy Practice University of Illinois at Chicago; Chicago Illinois

2. Department of Pharmacy Systems, Outcomes and Policy; University of Illinois at Chicago; Chicago Illinois

3. Center for Pharmacoepidemiology and Pharmacoeconomic Research; University of Illinois at Chicago; Chicago Illinois

4. Division of Health Policy and Administration; University of Illinois at Chicago; Chicago Illinois

Funder

National Heart, Lung, And Blood Institute of the National Institutes of Health

Janssen Health Economics and Outcomes Research

The Cranberry Institute

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1415/fullpdf

Reference24 articles.

1. Emergency hospitalizations for adverse drug events in older Americans;Budnitz;N Eng J Med,2011

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Eng J Med,2009

3. National trends in oral anticoagulant use in the United States, 2007 to 2011;Kirley;Circ Cardiovasc Qual Outcomes,2012

4. The United States Food and Drug Administration FDA drug safety communication: update on the risk for serious bleeding events with the anticoagulant Pradaxa http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm#data

5. Bleeding risk with dabigatran in the frail elderly;Harper;N Eng J Med,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spontaneous Reporting Systems;Principles and Practice of Pharmacovigilance and Drug Safety;2024

2. The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial;The Pharmacogenomics Journal;2023-09-09

3. Spontaneous reporting of post-market safety signals: what evidence should support regulatory action?;BMJ;2022-10-05

4. Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study;BMJ;2022-10-05

5. Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine;BMJ Case Reports;2022-05